Several studies have demonstrated that the expression of RNF2, a PcG protein, is associated with the tumor grade and prognosis, and could serve as a prognostic biomarker and therapeutic target in certain cancer types [22–24, 29, 30]. Here, RNF2 is linked to cancer.